ARTHRITIS ADVISORY COMMITTEE

February 8, 2001

Slides

NDA #21-042/S007, Vioxx (Rofecoxib, Merck)

Sponsor Presentation   pdf

Additional Slides   ppt   html

FDA Presentation

VIOXX - Gastrointestinal Outcome Research (VIGOR), Lourdes Villalba, MD   ppt   html

Gastrointestinal Review - Highlights of the VIGOR Trial, Lawrence Goldkind, MD   ppt   html

Cardiovascular Safety:  VIGOR Study, Shari L Targum, MD   pdf

Discussion on the meta analyses for cardiovascular risk assessment, Qian Li, Sc. D.   ppt   html

Summary, Lourdes Villalba, MD   ppt   html